CCCCC4 Therapeutics, Inc.
Is it growing?
Neither accelerating nor breaking down: nothing decisive, though operating margin widening (+97.5 points).
Trailing-twelve-month revenue vs a year earlier, from the company's own filings.
Trailing-twelve-month operating margin, -341.5% now against -439.0% a year earlier.
All from SEC EDGAR, as of Jun 30, 2026.
Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.
Is CCCC growing?
C4 Therapeutics, Inc.'s revenue has grown 30% a year over three years.
Revenue growth, 3-year annual rate · Biotechnology median +21% · compounding fast · compounded from trailing twelve-month revenue
- Years of annual history on file
- 7
Years of annual history on file · FY2019 to FY2025, as filed
Details›
- Revenue FY2021
- $46M
- Revenue FY2022
- $31M
- Revenue FY2023
- $21M
- Revenue FY2024
- $36M
- Revenue FY2025
- $36M
Annual income statements as filed with the SEC.